Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
PharmacyBiomedical Engineering
THE AI ANGLE
Simulating chemistry to design drug candidatesIsomorphic Labs raised $5 billion to advance its computationally designed drug candidates into clinical trials. The company builds chemistry simulation models derived from AlphaFold, with early preclinical work focused on oncology and immunology. Biomedical engineers and pharmacy researchers will now see these algorithmically designed compounds tested in clinical trial pipelines.
THE TEACHING ANGLE
Students and instructors can examine whether AI models that predict protein structures can reliably generate safe and effective therapies in human trials.Read the original at techcrunch.com Generate teaching or study materials
More in Pharmacy
- AI and nanotechnology enable five-minute drug screening from a single drop of urineMedical Xpress · November 18, 2026
- This tiny magnet could turn ordinary transistor circuits into artificial neuronsPhys.org — Technology · November 18, 2026